Vertical: CNMBase Year: 2025
Market Size (2025)
$668.51M
Projected (2032)
$1.30B
CAGR (2022–2032)
10.0%
Key Players
10+
Market Overview
The global fungal biopesticides market was valued at USD 668.5 million in 2025 and is projected to reach USD 1,299.6 million by 2032, registering a CAGR of 9.9% over the forecast period 2026–2032. In absolute terms, the market is expected to add USD 631.1 million in value between 2025 and 2032. Historically, the market expanded from USD 500.8 million in 2022 to USD 607.3 million in 2024, reflecting steady adoption of fungal biocontrol agents in integrated pest management (IPM) programmes, organic and residue-sensitive production systems, and large-scale row-crop agriculture in Latin America.
Fungal biopesticides use living entomopathogenic, antagonistic or nematophagous fungi, such as Trichoderma, Beauveria, Metarhizium, Cordyceps (Isaria), Lecanicillium, Purpureocillium and Coniothyrium, to control insect pests, soil-borne and foliar plant pathogens and plant-parasitic nematodes. Demand is supported by the progressive withdrawal of synthetic active ingredients in key markets, tightening maximum residue limits (MRLs) set by importing countries and retailers, the need for resistance management tools, and public programmes that promote bioinputs, most notably in Brazil and India.
Key Findings
By organism, Trichoderma was the largest segment in 2025 with USD 267.4 million (40.0% share), while Beauveria & Metarhizium is the fastest-growing segment with a CAGR of 10.9% over 2026–2032.
By crop type, Fruits & Vegetables was the largest segment in 2025 with USD 367.7 million (55.0% share), while Fruits & Vegetables is the fastest-growing segment with a CAGR of 10.4% over 2026–2032.
By formulation, Wettable Powder was the largest segment in 2025 with USD 300.8 million (45.0% share), while Liquid is the fastest-growing segment with a CAGR of 11.1% over 2026–2032.
By region, Latin America led the market in 2025 with USD 240.7 million (36.0% share), and Middle East & Africa is the fastest-growing region with a CAGR of 12.0%.
By country, Brazil was the leading country market in 2025 at USD 163.7 million, while UAE is the fastest-growing country with a CAGR of 13.3% over 2026–2032.
Asia Pacific, valued at USD 167.1 million in 2025, is projected to reach USD 342.9 million by 2032 at a CAGR of 10.8%, led by China (USD 56.8 million) and India (USD 46.8 million) in 2025.
Segmentation Summary
By organism, Trichoderma-based products accounted for USD 267.4 million in 2025, supported by their broad use as soil and seed-applied biofungicides against Fusarium, Rhizoctonia, Pythium and Sclerotinia. Beauveria & Metarhizium, the principal entomopathogenic fungi, accounted for USD 234.0 million and are expected to grow fastest at 10.9%, driven by large-area use against whiteflies, spittlebugs, borers and soil insects, particularly in Brazil. The Others segment, which includes Cordyceps (Isaria), Lecanicillium, Purpureocillium, Coniothyrium, Clonostachys and related genera, was valued at USD 167.1 million.
By crop type, Fruits & Vegetables represented USD 367.7 million in 2025, reflecting the high value per hectare, strict residue requirements and greenhouse use in this category. Cereals & Grains accounted for USD 167.1 million and Others (including oilseeds, pulses, sugarcane, cotton, turf and ornamentals) for USD 133.7 million. By formulation, Wettable Powder remained the largest format at USD 300.8 million, while Liquid formulations, valued at USD 234.0 million, are projected to grow fastest at 11.1% as oil dispersions and suspension concentrates improve shelf life and tank-mix compatibility.
Competitive Landscape Summary
The market is fragmented, with a mix of global biologicals specialists, diversified crop protection companies with biological divisions, and a large number of regional manufacturers in Brazil, India and China. Leading participants include Koppert, BioFirst Group (formerly Biobest Group, which owns BioWorks and Biotrop), Lallemand Plant Care, Certis Biologicals and Certis Belchim (Mitsui & Co.), Andermatt Group, UPL Ltd (through its Natural Plant Protection unit), Gowan Company (through Isagro), Vittia Group and IPL Biologicals. Since 2022, competition has been shaped by consolidation and portfolio transfers, including BioFirst's acquisitions of BioWorks and Biotrop, and Lallemand's acquisition of the Contans business from Bayer and the Met52 intellectual property from Novozymes.
Challenges and Opportunities
Key challenges include variable field performance under unfavourable temperature, humidity and UV conditions; limited shelf life and storage requirements for live propagules; the cost and duration of registration across fragmented national regimes; and price pressure in Brazil, where on-farm production and a growing number of registered products have increased competition. Opportunities lie in advanced liquid and oil-dispersion formulations, seed and in-furrow applications in row crops, nematode management, combination programmes with conventional chemistry for resistance management, and expansion in under-penetrated markets in the Middle East & Africa and Asia Pacific.
Future Outlook
The market is expected to nearly double between 2025 and 2032, rising from USD 668.5 million to USD 1,299.6 million. Growth will be supported by continued regulatory pressure on synthetic chemistry, faster registration pathways for low-risk microbial active substances, and investment by both specialists and large agrochemical companies in fermentation capacity and formulation technology. Middle East & Africa (12.0% CAGR) and Asia Pacific (10.8% CAGR) are expected to outpace the global average, while Latin America is expected to retain the largest regional share throughout the forecast period.
The Fungal Biopesticides Market market is projected to grow at a CAGR of 10.0% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Fungal biopesticides are plant protection products in which the active ingredient is a living fungus, applied as conidia (spores), blastospores, chlamydospores or mycelial fragments, that suppresses a target pest through infection, parasitism, antibiosis, competition or induced plant resistance. Entomopathogenic fungi such as Beauveria bassiana and Metarhizium spp. infect insects and mites by penetrating the cuticle; antagonistic fungi such as Trichoderma spp., Coniothyrium minitans and Clonostachys rosea suppress plant pathogens through mycoparasitism, competition for space and nutrients and the production of antimicrobial metabolites; and nematophagous fungi such as Purpureocillium lilacinum and Pochonia chlamydosporia parasitise nematode eggs and juveniles.
Included in the scope of this study are registered or commercially sold microbial pest control products based on fungal organisms (including yeast-like fungi), used as bioinsecticides, bioacaricides, biofungicides and bionematicides in agriculture and horticulture, across all formulation types. Excluded are bacterial biopesticides (such as Bacillus thuringiensis and Bacillus subtilis products), viral biopesticides (baculoviruses), botanical and biochemical pesticides, semiochemicals, macrobial biocontrol agents (predators and parasitoids), mycorrhizal and other biofertilisers and biostimulants not sold for pest control, and products containing only fungal-derived metabolites without viable fungal propagules.
Scope of the Study
The study covers the Global Fungal Biopesticides Market by organism, crop type, formulation and region. Market values are presented in USD Million for the historic years 2022–2024, the base year 2025 and the forecast years 2026–2032, with compound annual growth rates for 2026–2032.
By Organism: Trichoderma; Beauveria & Metarhizium; Others
By Crop Type: Fruits & Vegetables; Cereals & Grains; Others
By Formulation: Wettable Powder; Liquid; Granules
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Timeline: Historic years 2022–2024; base year 2025; forecast years 2026–2032
Currency: USD Million
Research Objectives
To estimate and forecast the size of the global fungal biopesticides market in value terms (USD Million) for 2022–2032.
To analyse the market by organism (Trichoderma; Beauveria & Metarhizium; Others) and identify the factors shaping the relative growth of antagonistic and entomopathogenic fungi.
To assess demand by crop type and formulation, including the shift from wettable powders towards liquid and granular formats.
To evaluate regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges influencing the adoption of fungal biocontrol agents.
To review the regulatory frameworks governing the registration and use of microbial pest control products in major markets.
To examine the value chain, competitive intensity (Porter's Five Forces) and macro-environmental factors (PESTEL) relevant to the market.
To profile the competitive landscape, including the positioning of leading companies and key developments from 2022 onward.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with defining the market and its segmentation, followed by extensive secondary research to build a fact base on products, registrations, companies, crop areas and regulatory developments. Primary research with industry participants is then used to validate and refine assumptions. Market size is estimated using both top-down and bottom-up approaches, and the results are triangulated before forecasts are developed for each segment, region and country.
Stage 1: Market definition, scope and segmentation framework
Stage 2: Secondary research and data collection
Stage 3: Primary research and validation with supply-side and demand-side participants
Stage 4: Market size estimation (top-down and bottom-up) and data triangulation
Stage 5: Forecasting, quality review and report preparation
Secondary Research
Secondary research drew on sources specific to the biological crop protection industry, including:
Industry associations: International Biocontrol Manufacturers Association (IBMA), Biological Products Industry Alliance (BPIA), CropLife International and its regional members, and the Brazilian Association of Biological Control Companies (ABCBio).
Government and regulatory bodies: the U.S. Environmental Protection Agency (EPA), the European Commission and the European Food Safety Authority (EFSA), Health Canada's Pest Management Regulatory Agency (PMRA), India's Central Insecticides Board & Registration Committee (CIB&RC), Brazil's Ministry of Agriculture and Livestock (MAPA), and China's Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA).
Registration databases: national pesticide registration databases and the EU Pesticides Database, used to track approved fungal active substances, strains and products.
Company filings and publications: annual reports, investor presentations, press releases and product labels of biological and agrochemical companies.
Trade journals and scientific literature: biocontrol, plant pathology and entomology journals, and specialist agricultural trade publications.
Statistical and paid databases: crop area and production statistics, agricultural input trade data and commercial company databases.
Primary Research
Primary research was conducted through in-depth interviews and discussions with participants across the value chain to validate secondary findings, understand pricing and adoption patterns, and obtain forward-looking views on market growth.
Supply side: executives and product managers of fungal biopesticide manufacturers, contract fermentation and formulation companies, distributors and agricultural retailers, and registration consultants.
Demand side: commercial growers of fruits, vegetables and row crops, greenhouse operators, agronomists and crop advisers, cooperatives, and researchers at agricultural universities and public research institutes.
Objectives: validate market size and segment splits, understand product performance and adoption barriers, assess pricing trends, identify regulatory and competitive developments, and test forecast assumptions.
Market Size Estimation
Top-down approach: the overall biopesticides market was established and the fungal biopesticides share was derived using the proportion of registered fungal products, company revenues from fungal biocontrol portfolios and industry expert inputs. This total was then allocated across organisms, crop types, formulations and regions.
Bottom-up approach: country-level demand was built from treated crop area, application rates, adoption levels and average product prices, and supplemented with revenue estimates of leading and regional suppliers. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of both approaches were compared and reconciled with primary research inputs. Differences were investigated and resolved to arrive at final market estimates for each segment and geography.
Forecasting Methodology
Forecasts were developed for each segment and country using the base-year estimates, historic growth patterns and an assessment of the factors expected to influence demand over 2026–2032. Factors considered include:
Regulatory developments affecting synthetic pesticides and the approval of microbial active substances
Growth in organic and residue-sensitive production and in protected cultivation
Adoption of biologicals in large-scale row crops, especially in Latin America
New product launches, formulation improvements and manufacturing capacity additions
Agricultural commodity prices, farm incomes and macroeconomic conditions
Public support programmes for bioinputs and IPM
Growth rates were reviewed with industry participants and adjusted where necessary to reflect regional differences in adoption maturity and regulatory conditions.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency and unit: USD Million
Assumptions and Limitations
Market values are expressed in USD at constant exchange rates; currency fluctuations are not separately modelled.
The regulatory environment is assumed to evolve along current lines, with no major unexpected restrictions on microbial active substances.
Values represent the manufacturer-level sales value of commercial products; on-farm and farmer-produced fungal inoculants that are not sold commercially are not included.
Company revenues for privately held firms are not publicly disclosed and have been assessed using available information and industry inputs.
Abrupt events such as extreme weather, pest outbreaks, trade disruptions or significant changes in commodity prices may cause actual results to differ from forecasts.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global fungal biopesticides market is fragmented. A group of international biological specialists, including Koppert, BioFirst Group, Lallemand Plant Care, Certis Biologicals and Andermatt Group, compete with diversified crop protection companies that have built biological portfolios, such as UPL and Gowan, and with a large number of regional and local manufacturers in Brazil, India, China and other countries. No single company holds a dominant position across all organisms, crops and regions.
Competition is based on strain performance and the breadth of registered uses, formulation quality and shelf life, manufacturing scale and cost, technical support to growers, and access to distribution. In regulated markets such as the U.S. and the EU, registration portfolios represent an important barrier to entry, whereas in Brazil and India competition is increasingly driven by price as the number of registered products grows. Since 2022, the competitive structure has been changing through acquisitions, transfers of fungal assets from large agrochemical and enzyme companies to biological specialists, investment in manufacturing capacity and distribution partnerships.
Key Player Positioning
Market Leaders
Koppert, BioFirst Group, Lallemand Plant Care and Certis Biologicals (with Certis Belchim in Europe) are positioned as leaders. Koppert, a family-owned company founded in 1967 in the Netherlands, offers Trichoderma (Trianum, Triario, Trichodermil), Beauveria (Boveril), Metarhizium (Metarril) and Lecanicillium (Mycotal) products and has a strong presence in Europe and Brazil; HAL Investments committed EUR 140 million of preferred capital to the company in February 2024. BioFirst Group, renamed from Biobest Group in April 2024, combines macrobial biocontrol with the microbial portfolios of BioWorks (RootShield, PRINCIPLE WP, BotryStop) and Biotrop (Trichoderma and Beauveria/Metarhizium products in Brazil); its parent Floridienne reported Life Sciences division revenue of EUR 538.3 million for 2025, which includes BioFirst. Lallemand Plant Care has built a broad fungal portfolio through acquisitions, including Contans (Coniothyrium minitans), Lalguard M52 (Metarhizium brunneum), Prestop and LALSTOP G46 (Clonostachys rosea) and LALNIX ACT (Purpureocillium lilacinum). Certis Biologicals, a wholly owned subsidiary of Mitsui & Co., markets BotaniGard and Mycotrol (Beauveria bassiana) and PFR-97 (Cordyceps fumosorosea) in the U.S., while Certis Belchim serves Europe.
Challengers
Andermatt Group, UPL and Vittia Group are positioned as challengers. Andermatt, founded in 1988 in Switzerland and independently owned, offers Beauveria bassiana, Metarhizium rileyi, Trichoderma atroviride and Trichoderma asperellum products manufactured by its South African subsidiary and is expanding in Latin America through acquisitions. UPL, which reported revenue of INR 51,839 crore for FY2026, markets biological products, including Beauveria bassiana- and Trichoderma-based products, through its Natural Plant Protection (NPP) unit and is expanding biological manufacturing in Brazil. Vittia Group, listed on B3 in Brazil, reported net revenue of BRL 820 million in 2025, of which its biological segment accounted for BRL 275.3 million, and markets Tricho-Turbo (Trichoderma asperellum), META-TURBO MAX (Metarhizium anisopliae) and BOVÉRIA-TURBO WP (Beauveria bassiana).
Niche and Regional Players
Gowan Company, through its acquisition of Isagro, markets Trichoderma-based biofungicides such as Remedier in Europe and Bio-Tam 2.0 in the U.S., and acquired Ceradis in 2025 to broaden its biocontrol technologies. IPL Biologicals, an Indian company operating since 1994 that reported turnover of INR 290 crore for FY2025–26, offers Trichoderma, Metarhizium and Pochonia products and is expanding exports through registration partnerships. The market also includes many regional producers, such as T. Stanes & Company in India and a large number of biological companies in Brazil and China, which compete mainly on price within their domestic markets.
Threat of New Entrants: Medium
Registration requirements, strain development and fermentation know-how create entry barriers in regulated markets such as the U.S. and EU.
Barriers are lower in some emerging markets, where many small local manufacturers produce generic Trichoderma and Beauveria products.
Established distribution relationships and brand trust favour incumbent suppliers.
Bargaining Power of Suppliers: Low
Fermentation substrates, carriers and packaging materials are widely available commodities.
Most leading companies own or license their strains and operate in-house fermentation.
Specialised contract manufacturers have some influence for companies without their own capacity.
Bargaining Power of Buyers: Medium
Large growers, cooperatives and distributors can negotiate prices, especially in Brazil.
On-farm production gives some large growers an alternative to commercial products.
Growers of high-value crops place a premium on proven efficacy and technical support, which limits price sensitivity.
Threat of Substitutes: High
Synthetic pesticides remain widely available, effective and often cheaper per application.
Bacterial, viral and biochemical biopesticides and macrobials compete for the same biological crop protection budgets.
Cultural practices and resistant crop varieties can reduce the need for any pest control product.
Competitive Rivalry: High
The market is fragmented, with many global, regional and local suppliers offering products based on similar organisms.
Rising numbers of registrations, particularly in Brazil, have increased price competition.
Companies compete on strain performance, formulation quality, shelf life and technical service.
Threat of New Entrants: Medium.
Bargaining Power of Suppliers: Low.
Bargaining Power of Buyers: Medium.
Threat of Substitutes: High.
Competitive Rivalry: High.
Market estimates by geography (2032)
InsightLatin America leads with $463.89M by 2032, while Middle East & Africa is projected to grow fastest at a 11.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $105.89M | $156.57M | $234.77M | 8.3% | 18% |
| Europe | $74.30M | $122.18M | $198.54M | 10.3% | 15% |
| Asia Pacific | $121.10M | $206.17M | $342.88M | 11.0% | 26% |
| Latin America | $179.46M | $290.63M | $463.89M | 10.0% | 36% |
| Middle East & Africa | $20.03M | $33.92M | $59.55M | 11.5% | 5% |
| Total | $500.77M | $809.46M | $1.30B | 10.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.30B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Trichoderma | $498.30M | 9.3% | 38% |
| Beauveria & Metarhizium | $483.62M | 11.1% | 37% |
| Others | $317.72M | 9.6% | 24% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Fungal Biopesticides Market covering market dynamics, competitive landscape, and strategic outlook.
The Fungal Biopesticides Market market is projected to reach $1.30B by 2032, growing at 10.0% CAGR. The Trichoderma segment holds the largest share.
The Global Fungal Biopesticides Market is shaped by regulatory, agronomic, economic and technological factors. This chapter presents a growth factor analysis followed by a discussion of the key drivers, restraints, opportunities, trends and challenges. The impact scores in the growth factor analysis table are analyst assessments, rated on a scale of 1 to 10, where a higher score indicates a stronger influence on the market during the period indicated.
Regulatory Pressure on Synthetic Pesticides and Residue Limits
Regulators in major agricultural markets continue to restrict the use of synthetic active ingredients that pose risks to human health, pollinators or the environment. In the European Union, approvals under Regulation (EC) No 1107/2009 have not been renewed for a number of widely used fungicides and insecticides, such as mancozeb and chlorpyrifos, leaving growers with fewer tools for disease and pest control. The European Commission's Farm to Fork Strategy set a target of reducing the use and risk of chemical pesticides by 50% by 2030, and Directive 2009/128/EC requires member states to promote integrated pest management with priority given to non-chemical methods. At the same time, retailers and importing countries apply strict maximum residue limits (MRLs), and export-oriented producers of fruits and vegetables in Latin America, Africa and Asia must comply with these requirements. Fungal biopesticides are generally exempt from residue tolerances or carry no MRL concerns, can often be applied close to harvest, and are compatible with organic certification. These characteristics make Trichoderma, Beauveria, Metarhizium and other fungal agents attractive replacements or complements for chemistries that are being withdrawn, and this regulatory pull is expected to remain a primary growth driver through 2032.
Rapid Adoption of Bioinputs in Brazilian Row Crops
Brazil has become the largest single country market for fungal biopesticides, driven by the use of biologicals over very large areas of soybean, maize, sugarcane, cotton and coffee. Metarhizium anisopliae is widely used against sugarcane spittlebug, Beauveria bassiana against whiteflies and other sucking pests, and Trichoderma species against white mould (Sclerotinia sclerotiorum) and other soil-borne diseases in soybean and beans. Public policy has reinforced this trend: the National Bioinputs Programme (Programa Nacional de Bioinsumos), created by Decree No. 10,375 of 2020, promotes the development and use of biological inputs, and Law No. 15,070, sanctioned in December 2024, established a dedicated legal framework for the production, registration and use of bioinputs, including on-farm production. Investment has followed, as shown by BioFirst Group's acquisition of a majority stake in Biotrop in December 2023 at an enterprise value of BRL 2.8 billion, Koppert's expansion of its Brazilian operations, and Vittia Group's financing from Finep in 2026 for biological research and development. These factors make Latin America the largest regional market and support sustained demand for entomopathogenic fungi.
Need for Resistance Management and Integrated Pest Management
Repeated use of chemical insecticides and fungicides with single modes of action has led to resistance in key pests and pathogens, including whiteflies, thrips, mites, aphids and Botrytis. Fungal biopesticides act through multiple mechanisms, such as cuticle penetration, mycoparasitism and competition, which makes the development of resistance less likely. Growers and advisers increasingly include fungal products in rotation or tank-mix programmes with conventional chemistry to extend the useful life of chemical actives and reduce the number of synthetic applications per season. In protected horticulture in Europe and North America, entomopathogenic fungi such as Beauveria bassiana, Cordyceps fumosorosea and Lecanicillium muscarium are used alongside macrobial biocontrol agents within IPM programmes, as many are compatible with beneficial insects. Public extension services and IPM programmes in India, China and Africa also promote Trichoderma seed and soil treatments, which supports demand for low-cost wettable powder and granular products.
Investment, Consolidation and Portfolio Expansion
Investor and corporate interest in biologicals has increased the resources available for product development, manufacturing capacity and market access. Since 2022, BioFirst Group has acquired BioWorks (2023) and Biotrop (2023), and in 2026 acquired full ownership of Biotrop. Lallemand Plant Care acquired the global Contans business from Bayer in January 2022 and the Met52 intellectual property from Novozymes in 2022. HAL Investments committed EUR 140 million in preferred capital to Koppert in February 2024 to fund expansion, in-licensing and acquisitions. In India, IPL Biologicals commissioned a new manufacturing facility in Vadodara in 2026, and UPL is expanding biological production in Brazil. This investment improves fermentation capacity, product quality and geographic reach, and the integration of fungal products into the portfolios of larger companies gives them access to broader distribution networks, which is expected to accelerate adoption over the forecast period.
Advanced Liquid and Oil-Dispersion Formulations
Formulation technology is a key differentiator. Oil dispersions and suspension concentrates can protect conidia from desiccation and UV radiation, improve spreading on leaf surfaces, extend shelf life and allow easier tank mixing and application through standard spray equipment. Liquid formulations are projected to be the fastest-growing formulation segment, with a CAGR of 11.1% over 2026–2032, creating opportunities for companies that invest in formulation research and production.
Seed Treatment, In-Furrow Use and Nematode Management
Trichoderma and nematophagous fungi can be applied as seed treatments or in-furrow at planting, which fits into existing row-crop operations and reduces application costs. With several chemical nematicides restricted in many markets, fungal agents such as Purpureocillium lilacinum and Pochonia chlamydosporia offer an opportunity in soybean, sugarcane, cotton, vegetables and banana. Expanding these uses in cereals, grains and other field crops would open large new areas to fungal biopesticides.
Expansion in Under-Penetrated Regions
Middle East & Africa is the fastest-growing region, with a CAGR of 12.0%, driven by expanding protected cultivation in the Gulf states and export-oriented fruit and vegetable production in Africa. Asia Pacific, with a CAGR of 10.8%, offers further potential as China and India promote reduced chemical pesticide use and natural farming. Companies that build local registration, manufacturing and distribution partnerships in these regions can gain early-mover advantages.
Variable Field Efficacy and Limited Shelf Life
Fungal biopesticides contain living organisms whose performance depends on environmental conditions. High temperatures, low humidity and ultraviolet radiation can reduce spore germination and infection, and their speed of action is generally slower than that of synthetic pesticides. Many products also require controlled storage conditions and have shorter shelf lives than chemical pesticides, which complicates distribution in hot climates and in markets with limited cold-chain infrastructure. Inconsistent results in the field can reduce grower confidence and slow repeat purchases.
Registration Cost, Time and Regulatory Fragmentation
Each new fungal strain and product must be registered separately in each country, with data on identity, efficacy, toxicology and environmental fate. Although several regulators have introduced specific data requirements for microorganisms, registration timelines can still extend over several years in some markets, and requirements differ between jurisdictions. For small and medium-sized biological companies, the cost of multi-country registration limits the speed at which products can be commercialised internationally.
Price Pressure and Competition from On-Farm Production
In Brazil, the rapid increase in the number of registered biological products and the practice of on-farm multiplication of microorganisms by large growers have intensified price competition. Listed Brazilian producers have reported pressure on margins in their biological segments. Low-cost and, in some cases, poor-quality products in developing markets can also undermine prices and grower confidence in fungal biocontrol.
Consolidation and Transfer of Fungal Assets to Specialists
Large agrochemical and enzyme companies have transferred certain fungal assets to biological specialists, while specialists have consolidated through acquisitions. Examples include Bayer's transfer of Contans and Novozymes' sale of Met52 intellectual property to Lallemand, and BioFirst's acquisitions of BioWorks and Biotrop. This trend is creating larger, more integrated biological companies with global reach.
Integration of Fungal Products into Combined Programmes
Suppliers increasingly position fungal biopesticides as part of programmes that combine biological and chemical products, biostimulants and macrobials, rather than as standalone replacements. Distribution partnerships between biological specialists and large crop protection companies support this trend.
Challenge: Quality Control and Grower Awareness
Product quality, including spore count, viability and freedom from contaminants, varies considerably among suppliers, especially in markets with large numbers of small manufacturers. Limited grower awareness of correct timing, storage and application practices also reduces performance. Training, extension services and quality standards remain important for long-term market development.
Challenge: Climate Variability
Changing temperature and rainfall patterns are altering pest and disease pressures and the conditions under which fungal agents perform. While new pest problems create demand, extreme heat and drought can reduce the efficacy of fungal biopesticides, requiring careful product selection, application timing and formulation improvements.
The value chain of the fungal biopesticides market extends from strain discovery and raw material supply to manufacturing, distribution and end use.
Raw materials and inputs: proprietary or licensed fungal strains from culture collections and bioprospecting programmes; fermentation substrates such as rice, other grains, molasses and nutrient media; carriers and inert materials such as talc, clay and kaolin; vegetable and mineral oils, surfactants, UV protectants and packaging.
Manufacturing: strain maintenance and inoculum preparation; solid-state fermentation (commonly used for aerial conidia of Beauveria, Metarhizium and Trichoderma) or liquid fermentation (for blastospores and chlamydospores); harvesting, drying and milling; formulation into wettable powders, liquids or granules; and quality control of spore count, viability and purity. Registration and regulatory compliance are completed before commercial sale.
Distribution and channels: national and regional distributors, agricultural retailers and cooperatives, direct sales to large growers and greenhouse operators, partnerships with multinational crop protection companies, and public procurement and subsidy programmes in some countries, such as India.
End users: growers of fruits and vegetables (open-field and protected cultivation), cereal, grain and oilseed producers, sugarcane, coffee, cotton and plantation crops, organic farms, and turf and ornamental producers.
North America
United States: fungal biopesticides are registered as microbial pesticides by the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), with review by the Biopesticides and Pollution Prevention Division and data requirements set out in 40 CFR Part 158, Subpart V. Many microbial active ingredients have been granted exemptions from the requirement of a food tolerance. Products for organic production must comply with the USDA National Organic Program (7 CFR Part 205).
Canada: registration under the Pest Control Products Act, administered by Health Canada's Pest Management Regulatory Agency (PMRA).
Mexico: pesticide registration is administered by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS).
Europe
European Union: microorganisms are approved as active substances under Regulation (EC) No 1107/2009. Commission Regulations (EU) 2022/1438, 2022/1439, 2022/1440 and 2022/1441 introduced specific approval criteria, data requirements and evaluation principles for microorganisms, applicable from November 2022. Many fungal strains qualify as low-risk active substances. MRLs are governed by Regulation (EC) No 396/2005, and Directive 2009/128/EC on the sustainable use of pesticides requires IPM.
United Kingdom: plant protection products are regulated by the Health and Safety Executive (HSE) under retained Regulation (EC) No 1107/2009 as it applies in Great Britain.
Asia Pacific
India: biopesticides are registered with the Central Insecticides Board & Registration Committee (CIB&RC) under the Insecticides Act, 1968 and the Insecticides Rules, 1971.
China: registration under the Regulations on Pesticide Administration, administered by the Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA).
Japan: registration under the Agricultural Chemicals Regulation Act, administered by the Ministry of Agriculture, Forestry and Fisheries (MAFF).
Latin America
Brazil: Law No. 14,785 of 2023 is the principal framework for pesticide registration, involving MAPA, ANVISA and IBAMA, and Law No. 15,070 of 2024 created a specific legal framework for bioinputs, including on-farm production for own use. The National Bioinputs Programme was established by Decree No. 10,375 of 2020.
Argentina: plant protection product registration is administered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: agricultural remedies, including biopesticides, are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Saudi Arabia and UAE: pesticide registration is administered by the Ministry of Environment, Water and Agriculture (MEWA) in Saudi Arabia and the Ministry of Climate Change and Environment (MOCCAE) in the UAE.
Jan 2022: Lallemand Plant Care; Acquisition; Took over the worldwide production and distribution of Contans (Coniothyrium minitans) from Bayer.
2022: Lallemand Plant Care; Acquisition; Acquired the Met52 (Metarhizium brunneum) intellectual property from Novozymes.
2022: Certis Biologicals; Product launch; Launched MeloCon LC, a Purpureocillium lilacinum strain 251 bionematicide, in the U.S.
Mar 2022: Mitsui & Co. (Certis Belchim); Merger; Created Certis Belchim by merging Certis Europe with Belchim Crop Protection.
Oct 2022: Certis Biologicals; Distribution; Began direct sales of BotaniGard and Mycotrol (Beauveria bassiana GHA) products.
Apr 2023: Lallemand Plant Care; Product launch; Rebranded Met52 as Lalguard M52 and announced a new oil-dispersion (OD) formulation.
May 2023: Koppert; Product launch; Launched a new generation of Mycotal (Lecanicillium muscarium) with improved efficacy and shelf life.
May 2023: Andermatt Group; Product launch; Launched Atroverde 77 (Trichoderma atroviride 77B) in Brazil for white mould control.
Jul 2023: Biobest Group; Acquisition; Completed the acquisition of BioWorks, a U.S. biological crop protection company.
Dec 2023: Biobest Group; Acquisition; Acquired approximately 85% of Biotrop (Brazil) at an enterprise value of BRL 2.8 billion.
Dec 2023: IPL Biologicals; Expansion; Signed an MoU with the Government of Gujarat for an INR 400 crore biofertiliser and biopesticide facility.
Feb 2024: Koppert; Investment; Received EUR 140 million of preferred capital from HAL Investments for expansion, in-licensing and M&A.
Apr 2024: BioFirst Group; Corporate; Biobest Group renamed itself BioFirst Group.
Apr 2024: UPL Ltd; Expansion; Announced expansion of production at its biologicals plant in Lucas do Rio Verde, Brazil.
Aug 2024: IPL Biologicals; Partnership; Partnered with AFEPASA (Spain) to register and market its microbial biopesticides globally.
Oct 2024: Andermatt Group; Acquisition; Acquired 80% of Agricheck, a distributor in Argentina.
Nov 2024: BioFirst Group (Biotrop); Expansion; Opened a bioinputs R&D centre in Gainesville, Florida, U.S.
Jul 2025: Koppert; Product launch; Launched Triario GR, a concentrated Trichoderma harzianum T-22 granular biofungicide.
Aug 2025: Vittia Group; Product launch; Launched META-TURBO MAX (Metarhizium anisopliae) and BOVÉRIA-TURBO WP (Beauveria bassiana) in Brazil.
Sep 2025: IPL Biologicals; Partnership; Signed an agreement with Mitsui India to register and distribute microbial biopesticides in the Philippines.
Oct 2025: Gowan Company; Acquisition; Acquired Ceradis (Netherlands), adding biocontrol and bio-mineral technologies.
May 2026: IPL Biologicals; Expansion; Commissioned an INR 200 crore manufacturing plant in Vadodara, Gujarat.
Jul 2026: Vittia Group; Investment; Secured up to BRL 153 million of Finep financing for a BRL 169 million biologicals R&D programme.
Jul 2026: Vittia Group; Expansion; Began commercial operations in Mexico.
Oct 2026: BioFirst Group; Acquisition; Acquired the remaining 14.71% stake in Biotrop, taking full ownership.
Political
Government programmes such as Brazil's National Bioinputs Programme and India's promotion of natural farming support the use of biological inputs.
Policy targets to reduce chemical pesticide use, such as the EU Farm to Fork Strategy, favour biological alternatives.
Trade policies and export requirements influence the adoption of residue-free crop protection by export-oriented producers.
Economic
Farm incomes and commodity prices affect growers' willingness to pay for biological products.
Lower development costs for biologicals compared with new synthetic actives attract investment and M&A.
Price competition in large markets such as Brazil affects supplier margins.
Social
Consumer demand for organic and residue-free food continues to rise.
Public concern about pesticide effects on health, pollinators and the environment supports biological solutions.
Grower awareness and technical knowledge of biological products vary widely between regions.
Technological
Advances in strain selection, genomics and fermentation improve product potency and production efficiency.
Oil-dispersion and other liquid formulations improve shelf life and field persistence.
Precision application technologies, including drones, support targeted delivery of biological products.
Environmental
Fungal biopesticides have low toxicity to non-target organisms and leave minimal residues.
Climate change alters pest pressure and the environmental conditions that affect fungal efficacy.
Compatibility with beneficial insects and pollinators supports use in IPM programmes.
Legal
Registration requirements for microorganisms differ by country, increasing compliance costs.
Specific EU data requirements for microorganisms, applicable from November 2022, aim to make approval procedures more appropriate for microbial products.
Brazil's bioinputs law of 2024 regulates on-farm production, affecting the competitive environment for commercial suppliers.
Profiles of 108 companies operating in the Fungal Biopesticides Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
4 interactive charts drawn from the Fungal Biopesticides Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Fungal Biopesticides Market By Formulation
Global Fungal Biopesticides Market By Crop Type
Global Fungal Biopesticides Market By Organism
Global Fungal Biopesticides Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
